Additional file 1 of HER3 functions as an effective therapeutic target in triple negative breast cancer to potentiate the antitumor activity of gefitinib and paclitaxel

Authors

Hui Lyu, LSU Health Sciences Center - New OrleansFollow
Fei Shen, Soochow University, CN
Sanbao Ruan, LSU Health Sciences Center - New Orleans
Congcong Tan, LSU Health Sciences Center - New OrleansFollow
Jundong Zhou, Nanjing Medical University
Ann D. Thor, University of Colorado Anschutz Medical Campus
Bolin Liu, LSU Health Sciences Center - New OrleansFollow

Document Type

Dataset

Publication Date

2023

Publication Title

Figshare

Abstract

Supplementary Material 1

DOI

10.6084/m9.figshare.24152514.v1

Comments

Original Article:

https://doi.org/10.1186/s12935-023-03055-w

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Recommended Citation

Lyu, Hui; Shen, Fei; Ruan, Sanbao; Tan, Congcong; Zhou, Jundong; Thor, Ann D.; and Liu, Bolin, "Additional file 1 of HER3 functions as an effective therapeutic target in triple negative breast cancer to potentiate the antitumor activity of gefitinib and paclitaxel" (2023). Data Sets. 49.
https://digitalscholar.lsuhsc.edu/datasets/49
10.6084/m9.figshare.24152514.v1